Explore
Validate
Learn
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [8]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN782926 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Forkhead Box A1 (FOXA1) (C-Term) antibody
- Antibody type
- Polyclonal
- Antigen
- Peptide from C-Terminus of the protein sequence according to NP_004487.2 Genename: FOXA1
- Description
- Ammonium Sulphate Precipitation followed by Antigen Affinity Chromatography using the immunizing peptide
- Reactivity
- Human, Mouse, Rat, Bovine, Porcine
- Host
- Goat
- Antigen sequence
C-GVYSRPVLNTS- Epitope
- C-Term
- Vial size
- 20 μg
- Concentration
- 0.5 mg/mL
- Storage
- Store undiluted at 2-8°C for one month or (in aliquots) at -20°C.
- Handling
- Avoid repeated freezing and thawing.
Submitted references Foxa1 functions as a pioneer transcription factor at transposable elements to activate Afp during differentiation of embryonic stem cells.
A FOXA1-binding enhancer regulates Hoxb13 expression in the prostate gland.
Cell-type selective chromatin remodeling defines the active subset of FOXA1-bound enhancers.
Genomic antagonism between retinoic acid and estrogen signaling in breast cancer.
FoxA1 translates epigenetic signatures into enhancer-driven lineage-specific transcription.
A cell-type-specific transcriptional network required for estrogen regulation of cyclin D1 and cell cycle progression in breast cancer.
Transcription factor interactions and chromatin modifications associated with p53-mediated, developmental repression of the alpha-fetoprotein gene.
Chromosome-wide mapping of estrogen receptor binding reveals long-range regulation requiring the forkhead protein FoxA1.
Taube JH, Allton K, Duncan SA, Shen L, Barton MC
The Journal of biological chemistry 2010 May 21;285(21):16135-44
The Journal of biological chemistry 2010 May 21;285(21):16135-44
A FOXA1-binding enhancer regulates Hoxb13 expression in the prostate gland.
McMullin RP, Dobi A, Mutton LN, Orosz A, Maheshwari S, Shashikant CS, Bieberich CJ
Proceedings of the National Academy of Sciences of the United States of America 2010 Jan 5;107(1):98-103
Proceedings of the National Academy of Sciences of the United States of America 2010 Jan 5;107(1):98-103
Cell-type selective chromatin remodeling defines the active subset of FOXA1-bound enhancers.
Eeckhoute J, Lupien M, Meyer CA, Verzi MP, Shivdasani RA, Liu XS, Brown M
Genome research 2009 Mar;19(3):372-80
Genome research 2009 Mar;19(3):372-80
Genomic antagonism between retinoic acid and estrogen signaling in breast cancer.
Hua S, Kittler R, White KP
Cell 2009 Jun 26;137(7):1259-71
Cell 2009 Jun 26;137(7):1259-71
FoxA1 translates epigenetic signatures into enhancer-driven lineage-specific transcription.
Lupien M, Eeckhoute J, Meyer CA, Wang Q, Zhang Y, Li W, Carroll JS, Liu XS, Brown M
Cell 2008 Mar 21;132(6):958-70
Cell 2008 Mar 21;132(6):958-70
A cell-type-specific transcriptional network required for estrogen regulation of cyclin D1 and cell cycle progression in breast cancer.
Eeckhoute J, Carroll JS, Geistlinger TR, Torres-Arzayus MI, Brown M
Genes & development 2006 Sep 15;20(18):2513-26
Genes & development 2006 Sep 15;20(18):2513-26
Transcription factor interactions and chromatin modifications associated with p53-mediated, developmental repression of the alpha-fetoprotein gene.
Nguyen TT, Cho K, Stratton SA, Barton MC
Molecular and cellular biology 2005 Mar;25(6):2147-57
Molecular and cellular biology 2005 Mar;25(6):2147-57
Chromosome-wide mapping of estrogen receptor binding reveals long-range regulation requiring the forkhead protein FoxA1.
Carroll JS, Liu XS, Brodsky AS, Li W, Meyer CA, Szary AJ, Eeckhoute J, Shao W, Hestermann EV, Geistlinger TR, Fox EA, Silver PA, Brown M
Cell 2005 Jul 15;122(1):33-43
Cell 2005 Jul 15;122(1):33-43
No comments: Submit comment
No validations: Submit validation data